RxSight, Inc. (NASDAQ: RXST) reported Q2 EPS of ($0.28), $0.19 better than the analyst estimate of ($0.47). Revenue for the quarter came in at $20.8 million versus the consensus estimate of $19.23 million.

For earnings history and earnings-related data on RxSight, Inc. (RXST) click here.